1. Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank.
- Author
-
Jiao XF, Li H, Zeng L, Yang H, Hu Y, Qu Y, Chen W, Sun Y, Zhang W, Zeng X, and Zhang L
- Subjects
- Humans, Female, United Kingdom epidemiology, Middle Aged, Cohort Studies, Adult, Aged, Biological Specimen Banks, Polycystic Ovary Syndrome epidemiology, Polycystic Ovary Syndrome drug therapy, Uterine Cervical Diseases epidemiology, Uterine Cervical Diseases chemically induced, Uterine Diseases chemically induced, Uterine Diseases epidemiology, Risk Factors, Uterine Cervical Neoplasms epidemiology, Proportional Hazards Models, UK Biobank, Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects, Ovarian Neoplasms epidemiology
- Abstract
Purpose: To examine the associations between use of statins and risks of various ovarian, uterine, and cervical diseases, including ovarian cancer, endometrial cancer, cervical cancer, ovarian cyst, polycystic ovarian syndrome, endometriosis, endometrial hyperplasia, endometrial polyp, and cervical polyp., Methods: We conducted a cohort study among female participants in the UK Biobank. Information on the use of statins was collected through verbal interview. Outcome information was obtained by linking to national cancer registry data and hospital inpatient data. We used Cox proportional hazards regression to examine the associations., Results: A total of 180,855 female participants (18,403 statin users and 162,452 non-users) were included. Use of statins was significantly associated with increased risks of cervical cancer (adjusted hazard ratio (HR), 1.55; 95% confidence interval (95% CI), 1.05-2.30) and polycystic ovarian syndrome (adjusted HR, 4.39; 95% CI, 1.68-11.49). However, we observed no significant association between use of statins and risk of ovarian cancer, endometrial cancer, ovarian cyst, endometriosis, endometrial hyperplasia, endometrial polyp, or cervical polyp., Conclusion: Our findings suggest that use of statins is associated with increased risks of cervical cancer and polycystic ovarian syndrome, but is not associated with increased or decreased risk of ovarian cancer, endometrial cancer, ovarian cyst, endometriosis, endometrial polyp, or cervical polyp., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF